UTHR has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. UTHR ranks #39 in insider activity out of 563 tracked companies in its industry.
Insider Trading Summary & Commentary
Automated executive transaction analysis for UTHR
Over the last 90 days, corporate insiders at UTHR (UTHR) engaged in a total of 100 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 60 were sales. The total volume of insider trading reached $279.86M.
The net insider activity for UTHR shows a net selling bias of $279.86M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Rothblatt Martine A (CHAIRPERSON, CEO), who traded 9.5K shares valued at $5.72M on Nov 3, 2026.
Live Market News & Developments
Aggregated real-time headlines for UTHR (UTHR)
6 updates
United Therapeutics Corporation (UTHR) Stock Price, News, Quote & History
Yahoo! Finance Canada2d ago
A family trust exercised options at $117.76 per share and sold United Therapeutics (UTHR) shares the same day.
Stock Titan14h ago
United Therapeutics(UTHR.US) Officer Sells US$5.63 Million in Common Stock
Moomoo2d ago
Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more
CNBC50d ago
United Therapeutics chairperson & CEO sells $5.5M in stock By Investing.com
Investing.com India2h ago
Why Is United Therapeutics (UTHR) Stock Rocketing Higher Today
Yahoo Finance50d ago
FAQs About UTHR Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for UTHR.
Based on SEC Form 4 disclosures, the Insider Confidence Score for UTHR is currently 15/100, which reflects a heavy distribution bias. This calculation accounts for a total of 0 purchases and 60 sales by company executives over the last 90 days.
The CEO Conviction Index for UTHR is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.
No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.